Blood-related proteomics

Journal of Proteomics

Volumn 73, Issue 3, 2010, Pages 483-507

  Liumbruno, Giancarlo ^a,b   D'Alessandro, Angelo ^a,c   Grazzini, Giuliano ^a   Zolla, Lello ^c  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAN GIOVANNI CALIBITA FATEBENEFRATELLI HOSPITAL   (Italy)

^c UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Blood; Leukocyte; Plasma; Platelets; Proteome; Red blood cell

Indexed keywords

BLOOD; BLOOD BANK; ERYTHROCYTE; GENOMICS; GRANULOCYTE; HUMAN; LEUKOCYTE; LYMPHOCYTE; MACROPHAGE; PLASMA; PRIORITY JOURNAL; PROTEOMICS; REVIEW; THROMBOCYTE;

BLOOD CHEMICAL ANALYSIS; BLOOD PLATELETS; ERYTHROCYTES; HUMANS; LEUKOCYTES; MODELS, BIOLOGICAL; PLASMA; PROTEOMICS;

EID: 72149092404     PISSN: 18743919     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jprot.2009.06.010     Document Type: Review

References (169)

1. Stein L.D. Human genome: end of the beginning. Nature 431 7011 (2004) 915-916
2. Evans W.E., and Relling M.V. Moving towards individualized medicine with pharmacogenomics. Nature 429 (2004) 464-468
3. Shah R.R. Pharmacogenetics in drug regulation: promise, potential and pitfalls. Philos Trans R Soc Lond B Biol Sci 360 1460 (2005) 1617-1638
4. Nebert D.W., Zhang G., and Vesell E.S. From human genetics and genomics to pharmacogenetics and pharmacogenomics: past lessons, future directions. Drug Metab Rev 40 2 (2008) 187-224
5. Kitano H. Introductions to systems biology. Tanpakushitsu Kakusan Koso 48 7 (2003) 789-793
6. Wasinger V.C., Cordwell S.J., Cerpa-Poljak A., Yan J.X., Gooley A.A., Wilkins M.R., et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16 (1995) 1090-1094
7. Wasinger V.C., Cordwell S.J., Cerpa-Poljak A., Yan J.X., Gooley A.A., Wilkins M.R., et al. Progress with gene-product mapping of the Mollicutes: Mycoplasma genitalium. Electrophoresis 16 (1995) 1090-1094
8. Marko-Varga G., and Fehniger T.E. Proteomics and disease: the challenges for technology and discovery. J Proteome Res 3 (2004) 167-178
9. Atallah E., and Schiffer C.A. Granulocyte transfusion. Curr Opin Hematol. 13 1 (2006) 45-49
10. Queloz P.A., Thadikkaran L., Crettaz D., Rossier J.S., Barelli S., and Tissot J.D. Proteomics and transfusion medicine: future perspectives. Proteomics 6 (2006) 5605-5614
11. Pasini E.M., Kirkegaard M., Mortensen P., Lutz H.U., Thomas A.W., and Mann M. In-depth analysis of the membrane and cytosolic proteome of red blood cells. Blood 108 (2006) 791-801
12. McRedmond J.P., Park S.D., Reilly D.F., Coppinger J.A., Maguire P.B., Shields D.C., et al. Integration of proteomics and genomics in platelets: a profile of platelet proteins and platelet-specific genes. Mol Cell Proteomics 3 (2004) 133-144
13. Anderson L., and Seilhamer J. A comparison of selected mRNA and protein abundances in human liver. Electrophoresis 18 3-4 (1997) 533-537
14. Anderson N.L., and Anderson N.G. Proteome and proteomics: new technologies, new concepts, and new words. Electrophoresis 19 11 (1998) 1853-1861
15. Cristea I.M., Gaskell S.J., and Whetton A.D. Proteomics techniques and their application to hematology. Blood 103 (2004) 3624-3634
16. de Hoog C.L., and Mann M. Proteomics. Annu Rev Genomics Hum Genet 5 (2004) 267-293
17. Tiselius A. Electrophoresis of serum globulin. I. Biochem J 31 2 (1937) 313-317
18. Page M.J., Griffiths T.A.M., Bleackley M.R., and MacGillivray R.T.A. Proteomics: applications relevant to transfusion medicine. Transfus Med Rev 20 (2006) 63-74
19. Anderson N.L., and Anderson N.G. The human plasma proteome: history, character, and diagnostic prospects. Mol Cell Proteomics 1 (2002) 845-867
20. Pieper R., Gatlin C.L., Makusky A.J., Russo P.S., Schatz C.R., Miller S.S., et al. The human serum proteome: display of nearly 3700 chromatographically separated protein spots on two dimensional electrophoresis gels and identification of 325 distinct proteins. Proteomics 3 (2003) 1345-1364
21. Echan L.A., Tang H.Y., Ali-Khan N., Lee K.B., and Speicher D.W. Depletion of multiple high-abundance proteins improves the protein profiling capacities of human serum and plasma. Proteomics 5 (2005) 3292-3303
22. Heller M., Michel P.E., Morier P., Crettaz D., Wenz C., Tissot J.D., et al. Two-stage Off-Gel isoelectric focusing: protein followed by peptide fractionation and application to proteome analysis of human plasma. Electrophoresis 26 6 (2005) 1174-1188
23. Boschetti E., and Righetti P.G. The art of observing rare protein species in proteomes with peptide ligand libraries. Proteomics (2009) 10.1002/pmic.200800389
24. Zolla L. Proteomics studies reveal important information on small molecule therapeutics: a case study on plasma proteins. Drug Discov Today 13 23-24 (2008) 1042-1051
25. Yocum A.K., Yu K., Oe T., and Blair I.A. Effect of immunoaffinity depletion of human serum during proteomic investigations. J Proteome Res 4 5 (2005) 1722-1731
26. Liumbruno G., D'Amici G.M., Grazzini G., and Zolla L. Transfusion medicine in the era of proteomics. J Proteomics 71 1 (2008) 34-45
27. Liumbruno G.M. Proteomics: applications in transfusion medicine. Blood Transfus 6 2 (2008) 70-85
28. Thiele T., Steil L., Völker U., and Greinacher A. Proteomics of blood-based therapeutics. BioDrugs 21 (2007) 179-193
29. Calvo K.R., Liotta L.A., and Petricoin E.F. Clinical proteomics: from biomarker discovery and cell signaling profiles to individualized personal therapy. Biosci Rep 25 1-2 (2005) 107-125
30. Unwin R.D., and Whetton A.D. How will haematologists use proteomics?. Blood Rev 21 6 (2007) 315-326
31. Greinacher A., and Warkentin T.E. Transfusion medicine in the era of genomics and proteomics. Transfus Med Rev 19 (2005) 288-294
32. Thadikkaran L., Siegenthaler M.A., Crettaz D., Queloz P.A., Schneider P., Tissot J.D., et al. Recent advances in blood-related proteomics. Proteomics 5 (2005) 3019-3034
33. Reddy K.S., and Perrotta P.L. Proteomics in transfusion medicine. Transfusion 44 (2004) 601-604
34. Unwin K.S., Morgan G.J., and Davies F.E. Proteomics and the haematologist. Clin Lab Haem 26 (2004) 77-86
35. Rosenblum B.B., Hanash S.M., Yew N., and Neel J.V. Two-dimensional electrophoretic analysis of erythrocyte membranes. Clin Chem 28 4:2 (1982) 925-931
36. Aminoff D., Rolfes-Curl A., and Supina E. Molecular biomarkers of aging: The red cell as a model. Arch Gerontol Geriatr 15 1 (1992) 7-15
37. Low T.Y., Seow T.K., and Chung M.C. Separation of human erythrocyte membrane associated proteins with one-dimensional and two-dimensional gel electrophoresis followed by identification with matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2 (2002) 1229-1239
38. Kakhniashvili D.G., Bulla Jr. L.A., and Goodman S.R. The human erythrocyte proteome: analysis by ion trap mass spectrometry. Mol Cell Proteomics 3 (2004) 501-509
39. Körbel S., Büchse T., Prietzsch H., Sasse T., Schümann M., Krause E., et al. Phosphoprotein profiling of erythropoietin receptor-dependent pathways using different proteomic strategies. Proteomics 5 1 (2005) 91-100
40. Tyan Y.C., Jong S.B., Liao J.D., Liao P.C., Yang M.H., Liu C.Y., et al. Proteomic profiling of erythrocyte proteins by proteolytic digestion chip and identification using two-dimensional electrospray ionization tandem mass spectrometry. J Proteome Res 4 (2005) 748-757
41. Bruschi M., Seppi C., Arena S., Musante L., Santucci L., Balduini C., et al. Proteomic analysis of erythrocyte membranes by soft Immobiline gels combined with differential protein extraction. J Proteome Res 4 4 (2005) 1304-1309
42. Goodman S.R., Kurdia A., Ammann L., Kakhniashvili D., and Daescu O. The human red blood cell proteome and interactome. Exp Biol Med (Maywood) 232 (2007) 1391-1408
43. Simó C., Bachi A., Cattaneo A., Guerrier L., Fortis F., Boschetti E., et al. Performance of combinatorial peptide libraries in capturing the low-abundance proteome of red blood cells. 1. Behavior of mono- to hexapeptides. Anal Chem 80 10 (2008) 3547-3565
44. Jiang M., Jia L., Jiang W., Hu X., Zhou H., Gao X., et al. Protein disregulation in red blood cell membranes of type 2 diabetic patients. Biochem Biophys Res Commun 309 (2003) 196-200
45. Brand M., Ranish J.A., Kummer N.T., Hamilton J., Igarashi K., Francastel C., et al. Dynamic changes in transcription factor complexes during erythroid differentiation revealed by quantitative proteomics. Nat Struct Mol Biol 11 (2004) 73-80
46. Florens L., Liu X., Wang Y., Yang S., Schwartz O., Peglar M., et al. Proteomics approach reveals novel proteins on the surface of malaria-infected erythrocytes. Mol Biochem Parasitol 135 (2004) 1-11
47. Kakhniashvili D.G., Griko N.B., Bulla Jr. L.A., and Goodman S.R. The proteomics of sickle cell disease: profiling of erythrocyte membrane proteins by 2D-DIGE and tandem mass spectrometry. Exp Biol Med 230 (2005) 787-792
48. Chou J., Choudhary P.K., and Goodman S.R. Protein profiling of sickle cell versus control RBC core membrane skeletons by ICAT technology and tandem mass spectrometry. Cell Mol Biol Lett 11 3 (2006) 326-337
49. Prabakaran S., Wengenroth M., Lockstone H.E., Lilley K., Leweke F.M., and Bahn S. 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia. J Proteome Res 6 1 (2007) 141-149
50. Council of Europe. Guide to the preparation, use and quality assurance of blood components. Recommendation no R (95) 15 on the preparation, use and quality assurance of blood components. 14th ed. (2008), Council of Europe Press, Strasbourg
51. Novotny V.M. Red cell transfusion in medicine: future challenges. Transfus Clin Biol 14 6 (2007) 538-541
52. Klein H.G., Spahn D.R., and Carson J.L. Red blood cell transfusion in clinical practice. Lancet 370 9585 (2007) 415-426
53. Högman C.F., and Meryman H.T. Red blood cells intended for transfusion: quality criteria revisited. Transfusion 46 1 (2006) 137-142
54. Ho J., Sibbald W.J., and Chin-Yee I.H. Effects of storage on efficacy of red cell transfusion: when is it not safe?. Crit Care Med 31 12 (2003) S687-S697
55. Hess J.R. An update on solutions for red cell storage. Vox Sang 91 1 (2006) 13-19
56. Valeri C.R., Ragno G., Pivacek L.E., Cassidy G.P., Srey R., Hansson-Wicher M., et al. An experiment with glycerol-frozen red blood cells stored at - 80 degrees C for up to 37 years. Vox Sang 79 3 (2000) 168-174
57. Yoshida T., AuBuchon J.P., Tryzelaar L., Foster K.Y., et al. Extended storage of red blood cells under anaerobic conditions. Vox Sang 92 1 (2007) 22-31
58. D'Amici G.M., Rinalducci S., and Zolla L. Proteomic analysis of RBC membrane protein degradation during blood storage. J Proteome Res 6 (2007) 3242-3255
59. Messana I., Ferroni L., Misiti F., Girelli G., Pupella S., Castagnola M., et al. Blood bank conditions and RBCs: the progressive loss of metabolic modulation. Transfusion 40 3 (2000) 353-360
60. Annis A.M., Glenister K.M., Killian J.J., and Sparrow R.L. Proteomic analysis of supernatants of stored red blood cell products. Transfusion 45 (2005) 1426-1433
61. Bosman G.J., Lasonder E., Luten M., Roerdinkholder-Stoelwinder B., Novotný V.M., et al. The proteome of red cell membranes and vesicles during storage in blood bank conditions. Transfusion 48 5 (2008) 827-835
62. Annis A.M., and Sparrow R.L. Storage duration and white blood cell content of red blood cell (RBC) products increases adhesion of stored RBCs to endothelium under flow conditions. Transfusion 46 (2006) 1561-1567
63. Sparrow R.L., and Patton K.A. Supernatant from stored red blood cell primes inflammatory cells: influence of prestorage white cell reduction. Transfusion 44 (2004) 722-773
64. Yoshida T., AuBuchon J.P., Dumont L.J., Gorham J.D., Gifford S.C., Foster K.Y., et al. The effects of additive solution pH and metabolic rejuvenation on anaerobic storage of red cells. Transfusion 48 10 (2008) 2096-2105
65. Dumont L.J., Yoshida T., and AuBuchon J.P. Anaerobic storage of red blood cells in a novel additive solution improves in vivo recovery. Transfusion 49 3 (2009) 458-464
66. Roux-Dalvai F., Gonzalez de Peredo A., Simó C., Guerrier L., Bouyssié D., Zanella A., et al. Extensive analysis of the cytoplasmic proteome of human erythrocytes using the peptide ligand library technology and advanced mass spectrometry. Mol Cell Proteomics 7 11 (2008) 2254-2269
67. Patel S.R., Hartwig J.H., and Italiano Jr. J.E. The biogenesis of platelets from megakaryocyte proplatelets. J Clin Invest 115 (2005) 3348-3354
68. Clemetson K.J., Capitanio A., and Lüscher E.F. High resolution two-dimensional gel electrophoresis of the proteins and glycoproteins of human blood platelets and platelet membranes. Biochim Biophys Acta 553 (1979) 11-24
69. Gravel P., Sanchez J.C., Walzer C., Golaz O., Hochstrasser D.F., Balant L.P., et al. Human blood platelet protein map established by two-dimensional polyacrylamide gel electrophoresis. Electrophoresis 16 (1995) 1152-1159
70. O'Neill E.E., Brock C.J., von Kriegsheim A.F., Pearce A.C., Dwek R.A., Watson S.P., et al. Towards complete analysis of the platelet proteome. Proteomics 2 (2002) 288-305
71. García A., Prabhakar S., Brock C.J., Pearce A.C., Dwek R.A., Watson S.P., et al. Extensive analysis of the human platelet proteome by two-dimensional gel electrophoresis and mass spectrometry. Proteomics 4 (2004) 656-668
72. Claeys D., Geering K., and Meyer B.J. Two-dimensional Blue Native/sodium dodecyl sulfate gel electrophoresis for analysis of multimeric proteins in platelets. Electrophoresis 26 (2005) 1189-1199
73. Immler D., Gremm D., Kirsch D., Spengler B., Presek P., and Meyer H.E. Identification of phosphorylated proteins from thrombin-activated human platelets isolated by two-dimensional gel electrophoresis by electrospray ionization-tandem mass spectrometry (ESI-MS/MS) and liquid chromatography-electrospray ionization-mass spectrometry (LC-ESI-MS). Electrophoresis 19 6 (1998) 1015-1023
74. Marcus K., Immler D., Sternberger J., and Meyer H.E. Identification of platelet proteins separated by two-dimensional gel electrophoresis and analyzed by matrix assisted laser desorption/ionization-time of flight-mass spectrometry and detection of tyrosine-phosphorylated proteins. Electrophoresis 21 13 (2000) 2622-2636
75. Marcus K., Moebius J., and Meyer H.E. Differential analysis of phosphorylated proteins in resting and thrombin-stimulated human platelets. Anal Bioanal Chem 376 7 (2003) 973-993
76. Maguire P.B., Wynne K.J., Harney D.F., O'Donoghue N.M., Stephens G., and Fitzgerald D.J. Identification of the phosphotyrosine proteome from thrombin activated platelets. Proteomics 2 6 (2002) 642-648
77. García A., Prabhakar S., Hughan S., Anderson T.W., Brock C.J., Pearce A.C., et al. Differential proteome analysis of TRAP-activated platelets: involvement of DOK-2 and phosphorylation of RGS proteins. Blood 103 6 (2004) 2088-2095
78. García A., Senis Y.A., Antrobus R., Hughes C.E., Dwek R.A., Watson S.P., et al. A global proteomics approach identifies novel phosphorylated signaling proteins in GPVI-activated platelets: involvement of G6f, a novel platelet Grb2-binding membrane adapter. Proteomics 6 19 (2006) 5332-5343
79. Lewandrowski U., Moebius J., Walter U., and Sickmann A. Elucidation of N-glycosylation sites on human platelet proteins: a glycoproteomic approach. Mol Cell Proteomics 5 2 (2006) 226-233
80. Coppinger J.A., Cagney G., Toomey S., Kislinger T., Belton O., McRedmond J.P., et al. Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions. Blood 103 6 (2004) 2096-2104
81. Moebius J., Zahedi R.P., Lewandrowski U., Berger C., Walter U., and Sickmann A. The human platelet membrane proteome reveals several new potential membrane proteins. Mol Cell Proteomics 4 11 (2005) 1754-1761
82. Guerrier L., Claverol S., Fortis F., Rinalducci S., Timperio A.M., Antonioli P., et al. Exploring the platelet proteome via combinatorial, hexapeptide ligand libraries. J Proteome Res 6 11 (2007) 4290-4303
83. Klinger M.H. The storage lesions of platelets: ultrastructural and functional aspects. Ann Hematol 73 (1996) 103-112
84. Seghatchian J., and Krailadsiri P. The platelet storage lesion. Transfus Med Rev 11 (1997) 130-144
85. Cardigan R., Turner C., and Harrison P. Current methods of assessing platelet function: relevance to transfusion medicine. Vox Sang 88 (2005) 153-163
86. Snyder E.L., Dunn B.E., Giometti C.S., Napychank P.A., Tandon N.N., Ferri P.M., et al. Protein changes occurring during storage of platelet concentrates. A two-dimensional gel electrophoresis analysis. Transfusion 27 (1987) 335-341
87. Wurtz V., Hechler B., Ohlmann P., Isola H., Schaeffer-Reiss C., Cazenave J.P., et al. Identification of platelet factor 4 and β-thromboglobulin by profiling and liquid chromatography tandem mass spectrometry of supernatant peptides in stored apheresis and buffy-coat platelet concentrates [letter]. Transfusion 47 (2007) 1099-1100
88. Thiele T., Steil L., Gebhard S., Scharf C., Hammer E., Brigulla M., et al. Profiling of alterations in platelet proteins during storage of platelet concentrates. Transfusion 47 (2007) 1221-1233
89. Glenister K.M., Payne K.A., and Sparrow R.L. Proteomic analysis of supernatant from pooled buffy-coat platelet concentrates throughout 7-day storage. Transfusion 48 (2008) 99-107
90. Li J., Xia Y., Bertino A.M., Coburn J.P., and Kuter D.J. The mechanism of apoptosis in human platelets during storage. Transfusion 40 11 (2000) 1320-1329
91. Ryu S.W., Suh I.B., and Cho Y. Protein profile changes in platelet concentrates according to storage and leukoreduction- analysis using proteomics technology. Korean J Lab Med 28 1 (2008) 53-63
92. Thon J.N., Schubert P., Duguay M., Serrano K., Lin S., Kast J., et al. Comprehensive proteomic analysis of protein changes during platelet storage requires complementary proteomic approaches. Transfusion 48 3 (2008) 425-435
93. Springer D., Miller J., Spinelli S., Pasa-Tolic L., Purvine S., Daly D., et al. Platelet proteome changes associated with diabetes and during platelet storage for transfusion. J Proteome Res (2009) 10.1021/pr800885j
94. Farrugia A. Plasma for fractionation: safety and quality issues. Haemophilia 10 (2004) 334-340
95. Fountoulakis M., Juranville J.F., Jiang L., Avila D., Röder D., Jakob P., et al. Depletion of the high-abundance plasma proteins. Amino Acids 27 3-4 (2004) 249-259
96. Tiselius A. Electrophoresis of serum globulin. I. Biochem J 31 2 (1937) 313-317
97. Anderson L., and Anderson N.G. High resolution two-dimensional electrophoresis of human plasma proteins. Proc Natl Acad Sci U S A 74 (1977) 5421-5425
98. O'Farrell P.H. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 250 10 (1975) 4007-4021
99. Anderson N.L., and Anderson N.G. A two-dimensional gel database of human plasma proteins. Electrophoresis 12 11 (1991) 883-906
100. Tracy R.P., Currie R.M., and Young D.S. Two-dimensional gel electrophoresis of serum specimens from a normal population. Clin Chem 28 4;2 (1982) 890-899
101. Harrison H., Miller K., Ober C., Refetoff S., Dick M., and Elias S. Identification of a serum protein polymorphism via two-dimensional electrophoresis. Family and population studies in two genetically isolated groups: North American Hutterites and Australian aborigines. Am J Hum Genet 48 2 (1991) 362-369
102. Gravel P., Golaz O., Walzer C., Hochstrasser D.F., Turler H., and Balant L.P. Analysis of glycoproteins separated by two-dimensional gel electrophoresis using lectin blotting revealed by chemiluminescence. Anal Biochem 221 1 (1994) 66-71
103. Henry H., Froehlich F., Perret R., Tissot J.D., Eilers-Messerli B., Lavanchy D., et al. Microheterogeneity of serum glycoproteins in patients with chronic alcohol abuse compared with carbohydrate-deficient glycoprotein syndrome type I. Clin Chem 45 9 (1999) 1408-1413
104. Hughes G.J., Frutiger S., Paquet N., Ravier F., Pasquali C., Sanchez J.C., et al. Plasma protein map: an update by microsequencing. Electrophoresis 13 9-10 (1992) 707-714
105. Richter R., Schulz-Knappe P., Schrader M., Ständker L., Jürgens M., Tammen H., et al. Composition of the peptide fraction in human blood plasma: database of circulating human peptides. J Chromatogr B Biomed Sci Appl 726 1-2 (1999) 25-35
106. Adkins J.N., Varnum S.M., Auberry K.J., Moore R.J., Angell N.H., Smith R.D., et al. Toward a human blood serum proteome: analysis by multidimensional separation coupled with mass spectrometry. Mol Cell Proteomics 1 12 (2002) 947-955
107. Liu X., Plasencia M., Ragg S., Valentine S.J., and Clemmer D.E. Development of high throughput dispersive LC-ion mobility-TOFMS techniques for analysing the human plasma proteome. Brief Funct Genomic Proteomic 3 2 (2004) 177-186
108. Shen Y., Zhang R., Moore R.J., Kim J., Metz T.O., Hixson K.K., et al. Automated 20 kpsi RPLC-MS and MS/MS with chromatographic peak capacities of 1000-1500 and capabilities in proteomics and metabolomics. Anal Chem 77 10 (2005) 3090-3100
109. Omenn G.S., States D.J., Adamski M., Blackwell T.W., Menon R., Hermjakob H., et al. Overview of the HUPO Plasma Proteome Project: results from the pilot phase with 35 collaborating laboratories and multiple analytical groups, generating a core dataset of 3020 proteins and a publicly-available database. Proteomics 5 13 (2005) 3226-3245
110. Li X., Gong Y., Wang Y., Wu S., Cai Y., He P., et al. Comparison of alternative analytical techniques for the characterisation of the human serum proteome in HUPO Plasma Proteome Project. Proteomics 5 13 (2005) 3423-3441
111. Zheng X., Baker H., and Hancock W.S. Analysis of the low molecular weight serum peptidome using ultrafiltration and a hybrid ion trap-Fourier transform mass spectrometer. J Chromatogr A 1120 1-2 (2006) 173-184
112. Smalley D.M., Root K.E., Cho H., Ross M.M., and Ley K. Proteomic discovery of 21 proteins expressed in human plasma-derived but not platelet-derived microparticles. Thromb Haemost 97 1 (2007) 67-80
113. Tissot J.D., Hochstrasser D.F., Schneider B., Morgenthaler J.J., and Schneider P. No evidence for protein modifications in fresh frozen plasma after photochemical treatment: an analysis by high-resolution two-dimensional electrophoresis. Br J Haematol 86 (1994) 143-146
114. Wagner S.J., Cifone M.A., Murli H., Dodd R.Y., and Myhr B. Mammalian genotoxicity assessment of methylene blue in plasma: implications for virus inactivation. Transfusion 35 (1995) 407-413
115. Crettaz D., Sensebe L., Vu D.H., Schneider P., Depasse F., Bienvenut W.V., et al. Proteomics of methylene blue photo-treated plasma before and after removal of the dye by an absorbent filter. Proteomics 4 (2004) 881-891
116. Steil L., Thiele T., Hammer E., Bux J., Kalus M., Völker U., et al. Proteomic characterization of freeze-dried human plasma: providing treatment of bleeding disorders without the need for a cold chain. Transfusion 48 11 (2008) 2356-2363
117. Qian W.J., Kaleta D.T., Petritis B.O., Jiang H., Liu T., Zhang X., et al. Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics 7 10 (2008) 1963-1973
118. Schenk S., Schoenhals G.J., de Souza G., and Mann M. A high confidence, manually validated human blood plasma protein reference set. BMC Med Genomics 1 (2008) 41
119. Zheng X., Wu S.L., Hincapie M., and Hancock W.S. Study of the human plasma proteome of rheumatoid arthritis. J Chromatogr A (2009) 10.1016/ j.chroma.2009.01.063
120. Muthusamy B., Hanumanthu G., Suresh S., Rekha B., Srinivas D., Karthick L., et al. Plasma Proteome Database as a resource for proteomics research. Proteomics 5 13 (2005) 3531-3536. http://www.plasmaproteomedatabase.org [Available at: www.plasmaproteomedatabase.org. Last accessed on the 9th June 2009]
121. Omenn G.S., Aebersold R., and Paik Y.K. 7(th) HUPO World Congress of Proteomics: launching the second phase of the HUPOPlasma Proteome Project (PPP-2) 16-20 August 2008, Amsterdam, The Netherlands. Proteomics 9 1 (2009) 4-6
122. Janzi M., Odling J., Pan-Hammarström Q., Sundberg M., Lundeberg J., Uhlén M., et al. Serum microarrays for large scale screening of protein levels. Mol Cell Proteomics 4 12 (2005) 1942-1947
123. Price T.H. Granulocyte transfusion: current status. Semin Hematol 44 (2007) 15-23
124. Morris C.F., Castro M.S., and Fontes W. Neutrophil proteome: lessons from different standpoints. Protein Pept Lett 15 9 (2008) 995-1001
125. Boussac M., and Garin J. Calcium-dependent secretion in human neutrophils: a proteomic approach. Electrophoresis 21 (2000) 665-672
126. Avram D., Romijn E.P., Pap E.H., Heck A.J., and Wirtz K.W. Identification of proteins in activated human neutrophils susceptible to tyrosyl radical attack. A proteomic study using a tyrosylating fluorophore. Proteomics 4 8 (2004) 2397-2407
127. Lominadze G., Powell D.W., Luerman G.C., Link A.J., Ward R.A., and McLeish K.R. Proteomic analysis of human neutrophil granules. Mol Cell Proteomics 4 10 (2005) 1503-1521
128. Feuk-Lagerstedt E., Movitz C., Pellmé S., Dahlgren C., and Karlsson A. Lipid raft proteome of the human neutrophil azurophil granule. Proteomics 7 2 (2007) 194-205
129. Füllekrug J., and Simons K. Lipid rafts and apical membrane traffic. Ann N Y Acad Sci 1014 (2004) 164-169
130. Razzaq T.M., Ozegbe P., Jury E.C., Sembi P., Blackwell N.M., and Kabouridis P.S. Regulation of T-cell receptor signalling by membrane microdomains. Immunology 113 4 (2004) 413-426
131. Nebl T., Pestonjamasp K.N., Leszyk J.D., Crowley J.L., Oh S.W., and Luna E.J. Proteomic analysis of a detergent-resistant membrane skeleton from neutrophil plasma membranes. J Biol Chem 277 45 (2002) 43399-43409
132. de Souza Castro M., de Sá N.M., Gadelha R.P., de Sousa M.V., Ricart C.A., Fontes B., et al. Proteome analysis of resting human neutrophils. Protein Pept Lett 13 5 (2006) 481-487
133. Katano M., Okamoto K., Arito M., Kawakami Y., Kurokawa M.S., Suematsu N., et al. Implication of GM-CSF induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res Ther 11 1 (2009) R3
134. Levi-Schaffer F., Temkin V., Simon H.U., Kettman J.R., Frey J.R., and Lefkovits I. Proteomic analysis of human eosinophil activation mediated by mast cells, granulocyte macrophage colony stimulating factor and tumor necrosis factor alpha. Proteomics 2 11 (2002) 1616-1626
135. Yoon S.W., Kim T.Y., Sung M.H., Kim C.J., and Poo H. Comparative proteomic analysis of peripheral blood eosinophils from healthy donors and atopic dermatitis patients with eosinophilia. Proteomics 5 7 (2005) 1987-1995
136. Barderas M.G., Dardé V.M., Durán M.C., Egido J., and Vivanco F. Characterization of circulating human monocytes by proteomic analysis. Methods Mol Biol 357 (2007) 319-328
137. Seong J.K., Kim D.K., Choi K.H., Oh S.H., Kim K.S., Lee S.S., et al. Proteomic analysis of the cellular proteins induced by adaptive concentrations of hydrogen peroxide in human U937 cells. Exp Mol Med 34 5 (2002) 374-378
138. Gadgil H.S., Pabst K.M., Giorgianni F., Umstot E.S., Desiderio D.M., Beranova-Giorgianni S., et al. Proteome of monocytes primed with lipopolysaccharide: analysis of the abundant proteins. Proteomics 3 9 (2003) 1767-1780
139. Dupont A., Tokarski C., Dekeyzer O., Guihot A.L., Amouyel P., Rolando C., et al. Two-dimensional maps and databases of the human macrophage proteome and secretome. Proteomics 4 6 (2004) 1761-1778
140. Jin M., Opalek J.M., Marsh C.B., and Wu H.M. Proteome comparison of alveolar macrophages with monocytes reveals distinct protein characteristics. Am J Respir Cell Mol Biol 31 3 (2004) 322-329
141. Dotzlaw H., Schulz M., Eggert M., and Neeck G. A pattern of protein expression in peripheral blood mononuclear cells distinguishes rheumatoid arthritis patients from healthy individuals. Biochim Biophys Acta 1696 1 (2004) 121-129
142. Zhang L., Zhu H., Lun Y., Yan D., Yu L., Du B., et al. Proteomic analysis of macrophages: a potential way to identify novel proteins associated with activation of macrophages for tumor cell killing. Cell Mol Immunol 4 5 (2007) 359-367
143. Jutras I., Houde M., Currier N., Boulais J., Duclos S., LaBoissière S., et al. Modulation of the phagosome proteome by interferon-gamma. Mol Cell Proteomics 7 4 (2008) 697-715
144. Shui W., Sheu L., Liu J., Smart B., Petzold C.J., Hsieh T.Y., et al. Membrane proteomics of phagosomes suggests a connection to autophagy. Proc Natl Acad Sci U S A 105 44 (2008) 16952-16957
145. Trost M., English L., Lemieux S., Courcelles M., Desjardins M., and Thibault P. The phagosomal proteome in interferon-gamma-activated macrophages. Immunity 30 1 (2009) 143-154
146. Polati R., Castagna A., Bossi A., Campostrini N., Zaninotto F., Timperio A.M., Zolla L., et al. High resolution preparation of monocyte-derived macrophages (MDM) protein fractions for clinical proteomics. Proteome Sci 7 (2009) 4
147. Akashi K., Traver D., Kondo M., and Weissman I.L. Lymphoid development from hematopoietic stem cells. Int J Hematol 69 4 (1999) 217-226
148. Kolb H.J., Mittermuller J., Clemm C., Holler E., Ledderose G., Brehm G., et al. Donor leukocyte transfusions for treatment of recurrent chronic myelogenous leukemia in marrow transplant patients. Blood 76 (1990) 2462-2465
149. Charron D. Autologous white blood cell transfusion: toward a younger immunity. Hum Immunol 68 10 (2007) 805-812
150. Nyman T.A., Rosengren A., Syyrakki S., Pellinen T.P., Rautajoki K., and Lahesmaa R. A proteome database of human primary T helper cells. Electrophoresis 22 20 (2001) 4375-4382
151. Rautajoki K., Nyman T.A., and Lahesmaa R. Proteome characterization of human T helper 1 and 2 cells. Proteomics 4 1 (2004) 84-92
152. Vuadens F., Gasparini D., Déon C., Sanchez J.C., Hochstrasser D.F., Schneider P., et al. Identification of specific proteins in different lymphocyte populations by proteomic tools. Proteomics 2 1 (2002) 105-111
153. Vuadens F., Rufer N., Kress A., Corthésy P., Schneider P., and Tissot J.D. Identification of swiprosin 1 in human lymphocytes. Proteomics 4 8 (2004) 2216-2220
154. Salonen J.M., Valmu L., Rönnholm G., Kalkkinen N., and Vihinen M. Proteome analysis of B-cell maturation. Proteomics 6 19 (2006) 5152-5168
155. Caron M., Imam-Sghiouar N., Poirier F., Le Caer J.P., Labas V., and Joubert-Caron R. Proteomic map and database of lymphoblastoid proteins. J Chromatogr B Anal Technol Biomed Life Sci 771 (2002) 197-209
156. Lefkovits I. Quantitative proteomics of lymphocytes. Comp Funct Genomics 4 5 (2003) 531-536
157. Hanna J., Fitchett J., Rowe T., Daniels M., Heller M., Gonen-Gross T., et al. Proteomic analysis of human natural killer cells: insights on new potential NK immune functions. Mol Immunol 42 4 (2005) 425-431
158. Stentz F.B., and Kitabchi A.E. Transcriptome and proteome expression in activated human CD4 and CD8 T-lymphocytes. Biochem Biophys Res Commun 324 2 (2004) 692-696
159. Rosengren A.T., Nyman T.A., and Lahesmaa R. Proteome profiling of interleukin-12 treated human T helper cells. Proteomics 5 12 (2005) 3137-3141
160. Wollscheid B., von Haller P.D., Yi E., Donohoe S., Vaughn K., Keller A., et al. Lipid raft proteins and their identification in T lymphocytes. Subcell Biochem 37 (2004) 121-152
161. Bini L., Pacini S., Liberatori S., Valensin S., Pellegrini M., Raggiaschi R., et al. Extensive temporally regulated reorganization of the lipid raft proteome following T-cell antigen receptor triggering. Biochem J 369 2 (2003) 301-309
162. Foster L.J., De Hoog C.L., and Mann M. Unbiased quantitative proteomics of lipid rafts reveals high specificity for signaling factors. Proc Natl Acad Sci U S A 100 10 (2003) 5813-5818
163. Loyet K.M., Ouyang W., Eaton D.L., and Stults J.T. Proteomic profiling of surface proteins on Th1 and Th2 cells. J Proteome Res 4 2 (2005) 400-409
164. Lund T.C., Anderson L.B., McCullar V., Higgins L., Yun G.H., Grzywacz B., et al. iTRAQ is a useful method to screen for membrane-bound proteins differentially expressed in human natural killer cell types. J Proteome Res 6 2 (2007) 644-653
165. Peirce M.J., Saklatvala J., Cope A.P., and Wait R. Mapping lymphocyte plasma membrane proteins: a proteomic approach. Methods Mol Med 136 (2007) 361-367
166. Truffa-Bachi P., Lefkovits I., and Frey J.R. Proteomic analysis of T cell activation in the presence of cyclosporin A: immunosuppressor and activator removal induces de novo protein synthesis. Mol Immunol 37 (2000) 21-28
167. Korecka A., Duszota A., and Korczak-Kowalska G. The role of the CD28 molecule in immunological tolerance. Postepy Hig Med Dosw 61 (2007) 74-82
168. Nunomura K., Nagano K., Itagaki C., Taoka M., Okamura N., Yamauchi Y., et al. Cell surface labeling and mass spectrometry reveal diversity of cell surface markers and signaling molecules expressed in undifferentiated mouse embryonic stem cells. Mol Cell Proteomics 4 12 (2005) 1968-1976
169. Righetti P.G., and Boschetti E. Sherlock Holmes and the proteome-a detective story. FEBS J 274 4 (2007) 897-905